Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
Article in Cell Reports Medicine (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
The cross-talk between macrophages and tumor cells as a target for cancer treatment
Article in Frontiers in Oncology (November 2023)
Clever-1 positive macrophages in breast cancer
Article in Breast Cancer Research and Treatment (August 2022)